Literature DB >> 23098428

Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley.

Majid Wani1, Dil Afroze, Muzamil Makhdoomi, Iqra Hamid, Bilal Wani, Gulzar Bhat, Rauf Wani, Khursheed Wani.   

Abstract

Cancer is a multi-factorial disease and variation in genetic susceptibility, due to inherited differences in the capacity to repair mismatches in the genome, is an important factor in the development of gastric cancer (GC), for example. Epigenetic changes, including aberrant methylation of 5/CpG islands in the promoter regions of mismatch repair (MMR) genes like hMLH1, have been implicated in the development of various types of GC. In the present study we evaluated the role of hMLH1 promoter hypermethylation in Kashmiri GC patients and controls, and assessed correlations with various dietary and lifestyle factors. The study included 70 GC patients (56 males and 14 females; age (mean ± S.D) 50 ± 11.4 years). Distinction between methylated and unmethylated was achieved with MS-PCR and DNA band patterns. The Chi-square test was applied to assess the risk due to promoter hypermethylation. We found a strikingly high frequency of promoter hypermethylation in GC cases than in normal samples (72.9% (51/70) in GC cases vs 20% (14/70) in normal samples (p=0.0001). We also observed a statistically significant association between methylated hMLH1 gene promoter and smoking, consumption of sundried vegetables and hot salted tea with the risk of GC. This study revealed that hMLH1 hypermethylation is strongly associated with GC and suggested roles for epigenetic changes in stomach cancer causation in the Kashmir valley.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098428     DOI: 10.7314/apjcp.2012.13.8.4177

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

1.  Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression.

Authors:  Meysam Moghbeli; Omeed Moaven; Bahram Memar; Hamid Reza Raziei; Azadeh Aarabi; Ezzat Dadkhah; Mohammad Mahdi Forghanifard; Fatemeh Manzari; Mohammad Reza Abbaszadegan
Journal:  J Gastrointest Cancer       Date:  2014-03

2.  Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.

Authors:  He-Ling Wang; Ping-Yi Zhou; Peng Liu; Yu Zhang
Journal:  Mol Biol Rep       Date:  2014-03-08       Impact factor: 2.316

Review 3.  Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.

Authors:  Jun Nakamura; Tomokazu Tanaka; Yoshihiko Kitajima; Hirokazu Noshiro; Kohji Miyazaki
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Epigenetic reduction of DNA repair in progression to gastrointestinal cancer.

Authors:  Carol Bernstein; Harris Bernstein
Journal:  World J Gastrointest Oncol       Date:  2015-05-15

Review 5.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

6.  Epigenetic changes of CDX2 in gastric adenocarcinoma.

Authors:  Ali Akbar Samadani; Novin Nikbakhsh; Maryam Pilehchian; Sadegh Fattahi; Haleh Akhavan-Niaki
Journal:  J Cell Commun Signal       Date:  2016-05-02       Impact factor: 5.782

7.  Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer.

Authors:  Chibin Pu; Weiguo Ren; Zhenqiang Sun; Xianbo Yu; Wei Yuan; Mingyu Huang; Shourong Shen; Xiaoyan Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).

Authors:  Ziliang Jin; Weihua Jiang; Liwei Wang
Journal:  Oncol Lett       Date:  2015-02-12       Impact factor: 2.967

9.  Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis.

Authors:  Peng Ye; Yu Shi; Anling Li
Journal:  Front Physiol       Date:  2018-04-17       Impact factor: 4.566

10.  Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer.

Authors:  Xie Zhang; Xuesong Zhang; Beilei Sun; Hongna Lu; Danping Wang; Xiaogang Yuan; Zhigang Huang
Journal:  Oncol Lett       Date:  2014-08-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.